Attached files
| file | filename |
|---|---|
| EX-21.1 - EXHIBIT 21-1 - Enumeral Biomedical Holdings, Inc. | s102860_ex21-1.htm |
| EX-32.2 - EXHIBIT 32-2 - Enumeral Biomedical Holdings, Inc. | s102860_ex32-2.htm |
| EX-31.2 - EXHIBIT 31-2 - Enumeral Biomedical Holdings, Inc. | s102860_ex31-2.htm |
| EX-32.1 - EXHIBIT 32-1 - Enumeral Biomedical Holdings, Inc. | s102860_ex32-1.htm |
| EX-31.1 - EXHIBIT 31-1 - Enumeral Biomedical Holdings, Inc. | s102860_ex31-1.htm |
| EX-10.35 - EXHIBIT 10.35 - Enumeral Biomedical Holdings, Inc. | s102860_ex10-35.htm |
| EX-10.31 - EXHIBIT 10.31 - Enumeral Biomedical Holdings, Inc. | s102860_ex10-31.htm |
| EX-10.37 - EXHIBIT 10-37 - Enumeral Biomedical Holdings, Inc. | s102860_ex10-37.htm |
| EX-10.38 - EXHIBIT 10-38 - Enumeral Biomedical Holdings, Inc. | s102860_ex10-38.htm |
| 10-K - FORM 10-K - Enumeral Biomedical Holdings, Inc. | s102860_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-203351) of Enumeral Biomedical Holdings, Inc. and Subsidiaries of our report dated March 30, 2016, which contains an explanatory paragraph regarding the Company’s ability to continue as a going concern, with respect to the consolidated financial statements which appear in this Annual Report on Form 10-K.
/s/ FRIEDMAN LLP
New York, New York
March 30, 2016